These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivatives. Krueger AC; Madigan DL; Beno DW; Betebenner DA; Carrick R; Green BE; He W; Liu D; Maring CJ; McDaniel KF; Mo H; Molla A; Motter CE; Pilot-Matias TJ; Tufano MD; Kempf DJ Bioorg Med Chem Lett; 2012 Mar; 22(6):2212-5. PubMed ID: 22342631 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-hepatitis C virus (HCV) activity of 3'-C-substituted-methyl pyrimidine and purine nucleosides. Choi WJ; Kim YM; Kim HO; Lee HW; Kim DE; Park KS; Chong Y; Jeong LS Bioorg Med Chem; 2010 Jul; 18(13):4812-20. PubMed ID: 20627592 [TBL] [Abstract][Full Text] [Related]
8. Exploration of the in vitro antiviral activity of a series of new pyrimidine analogues on the replication of HIV and HCV. Jafar NN; Al-Masoudi NA; Baqir SJ; Leyssen P; Pannecouque C Antivir Chem Chemother; 2012 Sep; 23(3):103-12. PubMed ID: 23010622 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4B. Zhang N; Zhang X; Zhu J; Turpoff A; Chen G; Morrill C; Huang S; Lennox W; Kakarla R; Liu R; Li C; Ren H; Almstead N; Venkatraman S; Njoroge FG; Gu Z; Clausen V; Graci J; Jung SP; Zheng Y; Colacino JM; Lahser F; Sheedy J; Mollin A; Weetall M; Nomeir A; Karp GM J Med Chem; 2014 Mar; 57(5):2121-35. PubMed ID: 24266880 [TBL] [Abstract][Full Text] [Related]
10. Computer-aided identification, synthesis and evaluation of substituted thienopyrimidines as novel inhibitors of HCV replication. Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Brancale A Eur J Med Chem; 2016 Nov; 123():31-47. PubMed ID: 27474921 [TBL] [Abstract][Full Text] [Related]
11. Discovery of potent sulfonamide P4-capped ketoamide second generation inhibitors of hepatitis C virus NS3 serine protease with favorable pharmacokinetic profiles in preclinical species. Bogen SL; Arasappan A; Velazquez F; Blackman M; Huelgas R; Pan W; Siegel E; Nair LG; Venkatraman S; Guo Z; Doll R; Shih NY; Njoroge FG Bioorg Med Chem; 2010 Mar; 18(5):1854-65. PubMed ID: 20149666 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication. Clark JL; Hollecker L; Mason JC; Stuyver LJ; Tharnish PM; Lostia S; McBrayer TR; Schinazi RF; Watanabe KA; Otto MJ; Furman PA; Stec WJ; Patterson SE; Pankiewicz KW J Med Chem; 2005 Aug; 48(17):5504-8. PubMed ID: 16107149 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of 9-(2-beta-C-methyl-beta-d-ribofuranosyl)-6-substituted purine derivatives as inhibitors of HCV RNA replication. Ding Y; Girardet JL; Hong Z; Lai VC; An H; Koh YH; Shaw SZ; Zhong W Bioorg Med Chem Lett; 2005 Feb; 15(3):709-13. PubMed ID: 15664842 [TBL] [Abstract][Full Text] [Related]
14. Novel potent inhibitors of hepatitis C virus (HCV) NS3 protease with cyclic sulfonyl P3 cappings. Chen KX; Vibulbhan B; Yang W; Nair LG; Tong X; Cheng KC; Njoroge FG Bioorg Med Chem Lett; 2009 Feb; 19(4):1105-9. PubMed ID: 19168351 [TBL] [Abstract][Full Text] [Related]
15. Phosphoramidate ProTides of 2'-C-methylguanosine as highly potent inhibitors of hepatitis C virus. Study of their in vitro and in vivo properties. McGuigan C; Gilles A; Madela K; Aljarah M; Holl S; Jones S; Vernachio J; Hutchins J; Ames B; Bryant KD; Gorovits E; Ganguly B; Hunley D; Hall A; Kolykhalov A; Liu Y; Muhammad J; Raja N; Walters R; Wang J; Chamberlain S; Henson G J Med Chem; 2010 Jul; 53(13):4949-57. PubMed ID: 20527890 [TBL] [Abstract][Full Text] [Related]